NU/1246-13: TREAT NMD Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
What the buyer wrote
TREAT-NMD was initially established as an FP6 EU funded Network of Excellence (2007 to 2012) coordinated by Prof Volker Straub, Newcastle University and was tasked with reshaping the research environment for rare inherited neuromuscular diseases. During the initial funding period TREAT-NMD Network of Excellence developed several tools and services to advance diagnosis, care and treatment for those living with neuromuscular diseases (http://www.treat-nmd.eu/). For the last 6 years, following the end of the FP6 EU grant, TREAT-NMD has been sustained as the TREAT-NMD Alliance, offering services through Newcastle University, funded by numerous income streams which include European grants, indu…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NU/1246-13: TREAT NMD Commercialisation of university research through provision of management skills to assist in successful spin-out company creation
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Work starts
- 30 Sep 2018
- Work ends
- 31 Mar 2019
- Kind of work
- Accountancy, audit and financial advice
Who the buyer named
The buyer published a contact address on this notice.